United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News PTC Therapeutics secures Russian approval for Translarna to treat Duchenne muscular dystrophy PTC Therapeutics, a leading US-based biotechnology company, has received marketing approval in Russia for its innovative drug, Translarna… bypharmanewsdailyDecember 6, 2020